Akinosoglou Karolina, Schinas Georgios, Papageorgiou Evangelia, Karampitsakos Theodoros, Dimakopoulou Vasiliki, Polyzou Eleni, Tzouvelekis Argyrios, Marangos Markos, Papageorgiou Despoina, Spernovasilis Nikolaos, Adonakis George
Department of Medicine, University of Patras, Patras 26504, Greece.
Department of Obstetrics and Gynecology, University General Hospital of Patras, Patras 26504, Greece.
World J Virol. 2024 Dec 25;13(4):96573. doi: 10.5501/wjv.v13.i4.96573.
The risk of severe coronavirus disease 2019 (COVID-19) in pregnant women is elevated.
To examine the outcomes of pregnant women with COVID-19 and report perinatal outcomes and complications, while providing a brief review of current literature.
The study included pregnant women presenting from April 2020 to February 2022 to the emergency department (ED) of a tertiary hospital. We retrospectively recorded the maternal and perinatal files, including patient epidemiological and clinical characteristics, laboratory values, outcomes, treatment modalities and associations were explored.
Among the 60 pregnant women, 25% required hospitalization, all of whom were symptomatic. Preterm delivery occurred in 30% of cases. Ten percent of neonates required admission to the neonatal intensive care unit, and 5% were classified as small for their gestational age. All mothers survived COVID-19 and pregnancy, with 6.6% requiring invasive mechanical ventilation. Preterm delivery rates did not differ between hospitalized and non-hospitalized pregnant women; composite unfavorable perinatal outcomes, including stillbirth, small for gestational age, or neonatal intensive care unit (ICU) admission, did not significantly increase in the cases hospitalized for COVID-19 ( = 0.09). The odds of hospitalization increased 2.3-fold for each day of delayed ED presentation [adj. OR (95%CI: 1.46-3.624), < 0.001]. Comorbidity status was an independent predictor of hospitalization, albeit with marginal significance [adj. OR = 16.13 (95%CI: 1.021-255.146), = 0.048]. No independent predictors of adverse fetal outcome (composite) were identified, and eventual hospitalization failed to reach statistical significance by a slight margin ( = 0.054).
Delayed ED presentation and comorbidities increase hospitalization odds. This study highlights the importance of continuous and specific guidance for managing pregnant COVID-19 patients, including timely and appropriate interventions to minimize maternal and perinatal morbidity and mortality.
孕妇患重症2019冠状病毒病(COVID-19)的风险有所升高。
研究COVID-19孕妇的结局,报告围产期结局及并发症,同时对当前文献进行简要综述。
本研究纳入了2020年4月至2022年2月期间到一家三级医院急诊科就诊的孕妇。我们回顾性记录了产妇和围产期档案,包括患者的流行病学和临床特征、实验室检查值、结局、治疗方式,并探讨了相关性。
在这60名孕妇中,25%需要住院治疗,所有住院患者均有症状。30%的病例发生了早产。10%的新生儿需要入住新生儿重症监护病房,5%的新生儿被归类为小于胎龄儿。所有母亲均从COVID-19和妊娠中存活下来,6.6%的母亲需要有创机械通气。住院和未住院孕妇的早产率无差异;COVID-19住院病例中,包括死产、小于胎龄儿或新生儿重症监护病房(ICU)入院在内的综合不良围产期结局并未显著增加(P = 0.09)。急诊科就诊延迟每一天,住院几率增加2.3倍[校正比值比(95%置信区间:1.46 - 3.624),P < 0.001]。合并症状态是住院的独立预测因素,尽管具有边缘显著性[校正比值比 = 16.13(95%置信区间:1.021 - 255.146),P = 0.048]。未发现不良胎儿结局(综合)的独立预测因素,最终住院情况未达统计学显著性,差距微小(P = 0.054)。
急诊科就诊延迟和合并症会增加住院几率。本研究强调了对COVID-19孕妇进行持续且针对性指导的重要性,包括及时且恰当的干预措施,以尽量降低孕产妇和围产期发病率及死亡率。